113 related articles for article (PubMed ID: 12642150)
1. Pharmacokinetics of D,L-3-hydroxy-3-ethyl-3-phenylpropionamide (HEPP) in pregnant rats at different stages of gestation and maternal-fetal disposition during late pregnancy.
Fletes Mdel R; Gómez-Martínez LE
Reprod Toxicol; 2003; 17(2):177-84. PubMed ID: 12642150
[TBL] [Abstract][Full Text] [Related]
2. Gestational age dependency in the prenatal toxicity and in the disposition kinetics of the novel anticonvulsant HEPP (D,L-3-hydroxy-3-ethyl-3-phenylpropionamide) after subcutaneous administration in pregnant rats.
Gómez-Martínez LE
Int J Toxicol; 2007; 26(3):237-46. PubMed ID: 17564905
[TBL] [Abstract][Full Text] [Related]
3. Plasma determination of the novel anticonvulsant D,L-3-hydroxy-3-ethyl-3-phenylpropionamide and preliminary pharmacokinetic studies in the rat.
Gomez LE; Lehmann PA
J Chromatogr; 1992 Mar; 575(2):306-10. PubMed ID: 1629310
[TBL] [Abstract][Full Text] [Related]
4. Disposition kinetics of HEPP in rats after intravenous, oral, and intraperitoneal administration. Correlation of plasma and brain levels with the anticonvulsant effect.
Gómez LE; Cueva-Rolón R; Lehmann PA
Biopharm Drug Dispos; 1995 Mar; 16(2):77-89. PubMed ID: 7780049
[TBL] [Abstract][Full Text] [Related]
5. Single dose pharmacokinetics of HEPP, a new anticonvulsant in normal healthy volunteers.
González-Esquivel DF; Rubio-Donnadieu F; Carvajal-Sandoval G; Jung HC
Biopharm Drug Dispos; 1998 Dec; 19(9):583-7. PubMed ID: 9872340
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic interaction in rabbits between a new anticonvulsant, DL-3-hydroxy-3-ethyl-3-phenylpropionamide, and phenytoin.
Medina L; García L; Pérez R; Fernández A; Jung H
J Pharm Pharmacol; 1998 Dec; 50(12):1393-6. PubMed ID: 10052855
[TBL] [Abstract][Full Text] [Related]
7. 2,3,7,8-Tetrachlorodibenzo-p-dioxin in pregnant Long Evans rats: disposition to maternal and embryo/fetal tissues.
Hurst CH; Abbott BD; DeVito MJ; Birnbaum LS
Toxicol Sci; 1998 Oct; 45(2):129-36. PubMed ID: 9848119
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of HEPP, a new anticonvulsant, in healthy subjects and rabbits after multiple doses.
González-Esquivel DF; Pérez RM; Cook HJ
Biopharm Drug Dispos; 2004 Mar; 25(2):85-90. PubMed ID: 14872556
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of the novel anticonvulsant HEPP after single intravenous administration of three different doses in dogs.
Gómez LE; Lehmann PA
Biopharm Drug Dispos; 1995 Mar; 16(2):105-12. PubMed ID: 7780044
[TBL] [Abstract][Full Text] [Related]
10. Distribution of saquinavir, methadone, and buprenorphine in maternal brain, placenta, and fetus during two different gestational stages of pregnancy in mice.
Coles LD; Lee IJ; Hassan HE; Eddington ND
J Pharm Sci; 2009 Aug; 98(8):2832-46. PubMed ID: 19116954
[TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics of valproic acid in pregnant sheep after maternal and fetal intravenous bolus administration.
Gordon JD; Riggs KW; Rurak DW; Kwan E; Hall C; Abbott FS
Drug Metab Dispos; 1995 Dec; 23(12):1383-9. PubMed ID: 8689948
[TBL] [Abstract][Full Text] [Related]
12. Metoclopramide pharmacokinetics in pregnant and nonpregnant sheep.
Riggs KW; Axelson JE; Gruber NC; McErlane BA; McMorland GH; Rurak DW
J Pharm Sci; 1988 May; 77(5):373-9. PubMed ID: 3411454
[TBL] [Abstract][Full Text] [Related]
13. Disposition of valproic acid in maternal, fetal, and newborn sheep. I: placental transfer, plasma protein binding, and clearance.
Kumar S; Wong H; Yeung SA; Riggs KW; Abbott FS; Rurak DW
Drug Metab Dispos; 2000 Jul; 28(7):845-56. PubMed ID: 10859159
[TBL] [Abstract][Full Text] [Related]
14. Lack of interaction between HEPP, a new antiepileptic agent, and carbamazepine in rabbits.
García AL; Medina RL; Pérez MR; Jung CH
Biopharm Drug Dispos; 2003 Jul; 24(5):205-9. PubMed ID: 12784320
[TBL] [Abstract][Full Text] [Related]
15. Gestation time-dependent pharmacokinetics of intravenous (+)-methamphetamine in rats.
White S; Laurenzana E; Hendrickson H; Gentry WB; Owens SM
Drug Metab Dispos; 2011 Sep; 39(9):1718-26. PubMed ID: 21632964
[TBL] [Abstract][Full Text] [Related]
16. Tissue disposition of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in maternal and developing long-evans rats following subchronic exposure.
Hurst CH; DeVito MJ; Birnbaum LS
Toxicol Sci; 2000 Oct; 57(2):275-83. PubMed ID: 11006357
[TBL] [Abstract][Full Text] [Related]
17. Maternal undernutrition during late gestation-induced intrauterine growth restriction in the rat is associated with impaired placental GLUT3 expression, but does not correlate with endogenous corticosterone levels.
Lesage J; Hahn D; Léonhardt M; Blondeau B; Bréant B; Dupouy JP
J Endocrinol; 2002 Jul; 174(1):37-43. PubMed ID: 12098661
[TBL] [Abstract][Full Text] [Related]
18. Maternal-fetal disposition of glyburide in pregnant mice is dependent on gestational age.
Shuster DL; Risler LJ; Liang CK; Rice KM; Shen DD; Hebert MF; Thummel KE; Mao Q
J Pharmacol Exp Ther; 2014 Aug; 350(2):425-34. PubMed ID: 24898265
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy in a pregnant rat model. 1. Mitomycin-C: pregnancy-specific kinetics and placental transfer.
Boike GM; Deppe G; Young JD; Gove NL; Bottoms SF; Malone JM; Malviya VK; Sokol RJ
Gynecol Oncol; 1989 Aug; 34(2):187-90. PubMed ID: 2502487
[TBL] [Abstract][Full Text] [Related]
20. Maternal-fetal pharmacokinetics of zidovudine in rats.
Huang CS; Boudinot FD; Feldman S
J Pharm Sci; 1996 Sep; 85(9):965-70. PubMed ID: 8877888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
